These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 29439669)

  • 21. miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway.
    Li W; Yi J; Zheng X; Liu S; Fu W; Ren L; Li L; Hoon DSB; Wang J; Du G
    Clin Epigenetics; 2018; 10():64. PubMed ID: 29796115
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Zhang TJ; Zhou JD; Zhang W; Lin J; Ma JC; Wen XM; Yuan Q; Li XX; Xu ZJ; Qian J
    Clin Epigenetics; 2018; 10():47. PubMed ID: 29643943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1).
    Zhu Q; Gong L; Wang J; Tu Q; Yao L; Zhang JR; Han XJ; Zhu SJ; Wang SM; Li YH; Zhang W
    BMC Cancer; 2016 Oct; 16(1):806. PubMed ID: 27756250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.
    Larmonie NSD; Arentsen-Peters TCJM; Obulkasim A; Valerio D; Sonneveld E; Danen-van Oorschot AA; de Haas V; Reinhardt D; Zimmermann M; Trka J; Baruchel A; Pieters R; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M
    Oncogene; 2018 Jan; 37(1):107-115. PubMed ID: 28892045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term observation reveals high-frequency engraftment of human acute myeloid leukemia in immunodeficient mice.
    Paczulla AM; Dirnhofer S; Konantz M; Medinger M; Salih HR; Rothfelder K; Tsakiris DA; Passweg JR; Lundberg P; Lengerke C
    Haematologica; 2017 May; 102(5):854-864. PubMed ID: 28183848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of lncRNA NEAT1 regulated by miR-194-5p/DNMT3A facilitates acute myeloid leukemia.
    Duan MY; Li M; Tian H; Tang G; Yang YC; Peng NC
    Blood Cells Mol Dis; 2020 May; 82():102417. PubMed ID: 32179410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid Leukemia.
    Bhayadia R; Krowiorz K; Haetscher N; Jammal R; Emmrich S; Obulkasim A; Fiedler J; Schwarzer A; Rouhi A; Heuser M; Wingert S; Bothur S; Döhner K; Mätzig T; Ng M; Reinhardt D; Döhner H; Zwaan CM; van den Heuvel Eibrink M; Heckl D; Fornerod M; Thum T; Humphries RK; Rieger MA; Kuchenbauer F; Klusmann JH
    J Clin Oncol; 2018 Apr; 36(10):1007-1016. PubMed ID: 29432078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-26a-5p and microRNA-23b-3p up-regulate peroxiredoxin III in acute myeloid leukemia.
    Jiang W; Min J; Sui X; Qian Y; Liu Y; Liu Z; Zhou H; Li X; Gong Y
    Leuk Lymphoma; 2015 Feb; 56(2):460-71. PubMed ID: 24828865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of human RNase-L by the miR-29 family reveals a novel oncogenic role in chronic myelogenous leukemia.
    Lee TY; Ezelle HJ; Venkataraman T; Lapidus RG; Scheibner KA; Hassel BA
    J Interferon Cytokine Res; 2013 Jan; 33(1):34-42. PubMed ID: 23113544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting the RAS/MAPK pathway with miR-181a in acute myeloid leukemia.
    Huang X; Schwind S; Santhanam R; Eisfeld AK; Chiang CL; Lankenau M; Yu B; Hoellerbauer P; Jin Y; Tarighat SS; Khalife J; Walker A; Perrotti D; Bloomfield CD; Wang H; Lee RJ; Lee LJ; Marcucci G
    Oncotarget; 2016 Sep; 7(37):59273-59286. PubMed ID: 27517749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HoxB3 promotes prostate cancer cell progression by transactivating CDCA3.
    Chen J; Zhu S; Jiang N; Shang Z; Quan C; Niu Y
    Cancer Lett; 2013 Apr; 330(2):217-24. PubMed ID: 23219899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA hypermethylation-induced miR-182 silence targets BCL2 and HOXA9 to facilitate the self-renewal of leukemia stem cell, accelerate acute myeloid leukemia progression, and determine the sensitivity of BCL2 inhibitor venetoclax.
    Ye S; Xiong F; He X; Yuan Y; Li D; Ye D; Shi L; Lin Z; Zhao M; Feng S; Zhou B; Weng H; Hong L; Ye H; Gao S
    Theranostics; 2023; 13(1):77-94. PubMed ID: 36593968
    [No Abstract]   [Full Text] [Related]  

  • 33. miR-638 regulates differentiation and proliferation in leukemic cells by targeting cyclin-dependent kinase 2.
    Lin Y; Li D; Liang Q; Liu S; Zuo X; Li L; Sun X; Li W; Guo M; Huang Z
    J Biol Chem; 2015 Jan; 290(3):1818-28. PubMed ID: 25451924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-34b Targets HSF1 to Suppress Cell Survival in Acute Myeloid Leukemia.
    Li G; Song Y; Zhang Y; Wang H; Xie J
    Oncol Res; 2016; 24(2):109-16. PubMed ID: 27296951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A minicircuitry of microRNA-9-1 and RUNX1-RUNX1T1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia.
    Fu L; Shi J; Liu A; Zhou L; Jiang M; Fu H; Xu K; Li D; Deng A; Zhang Q; Pang Y; Guo Y; Hu K; Zhou J; Wang Y; Huang W; Jing Y; Dou L; Wang L; Xu K; Ke X; Nervi C; Li Y; Yu L
    Int J Cancer; 2017 Feb; 140(3):653-661. PubMed ID: 27770540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A minicircuitry comprised of microRNA-9 and SIRT1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia.
    Zhou L; Fu L; Lv N; Chen XS; Liu J; Li Y; Xu QY; Huang S; Zhang XD; Dou LP; Wang LL; Li YH; Yu L
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):786-794. PubMed ID: 28272704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia.
    Niederwieser C; Kohlschmidt J; Volinia S; Whitman SP; Metzeler KH; Eisfeld AK; Maharry K; Yan P; Frankhouser D; Becker H; Schwind S; Carroll AJ; Nicolet D; Mendler JH; Curfman JP; Wu YZ; Baer MR; Powell BL; Kolitz JE; Moore JO; Carter TH; Bundschuh R; Larson RA; Stone RM; Mrózek K; Marcucci G; Bloomfield CD
    Leukemia; 2015 Mar; 29(3):567-75. PubMed ID: 25204569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia.
    Fischer J; Rossetti S; Datta A; Eng K; Beghini A; Sacchi N
    Mol Cancer; 2015 Jan; 14():7. PubMed ID: 25612891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zinc finger protein 382 is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia patients.
    Tao YF; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Xu LX; Li ZH; Wang NN; Du XJ; Sun LC; Zhao H; Fang F; Su GH; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
    Int J Mol Med; 2014 Dec; 34(6):1505-15. PubMed ID: 25319049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A SALL4/MLL/HOXA9 pathway in murine and human myeloid leukemogenesis.
    Li A; Yang Y; Gao C; Lu J; Jeong HW; Liu BH; Tang P; Yao X; Neuberg D; Huang G; Tenen DG; Chai L
    J Clin Invest; 2013 Oct; 123(10):4195-207. PubMed ID: 24051379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.